Background & Aims: Adverse muscle composition (MC) (i.e., low muscle volume and high muscle fat) has previously been linked to poor functional performance and comorbidities in non-alcoholic fatty liver disease (NAFLD). In this study we aimed to investigate associations of all-cause mortality with liver fat, NAFLD, and MC in the UK Biobank imaging study. Methods: Magnetic resonance images of 40,174 participants were analyzed for liver proton density fat fraction (PDFF), thigh fat-free muscle volume (FFMV) z-score, and muscle fat infiltration (MFI) using the AMRA® Researcher. Participants with NAFLD were sex-, age-, and BMI-matched to participants without NAFLD with low alcohol consumption. Adverse MC was identified using previously publi...
© 2022 AGA InstituteBackground & Aims: Sarcopenia and myosteatosis are associated with advanced ...
Background: Retrospective cross‐sectional studies link sarcopenia and myosteatosis with non‐alcoholi...
Nonalcoholic fatty liver disease (NAFLD) can be seen as a manifestation of overnutrition. The muscle...
Background & Aims: Adverse muscle composition (MC) (i.e., low muscle volume and high muscle fat)...
Background & Aim: Cross-sectional studies have shown lower muscle mass and strength as risk fa...
Background Adverse muscle composition (MC) as measured by magnetic resonance imaging has previously ...
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide. Obesity is a...
<p><strong>Objectives</strong>: Sarcopenia is a known risk factor for non-alcoholi...
Studies exploring the relationship between muscle fat content and non-alcoholic fatty liver disease ...
Low skeletal muscle mass (LSMM) has emerged as a potential risk factor for non-alcoholic fatty liver...
BACKGROUND AND AIMS Although non-alcoholic fatty liver disease (NAFLD) is linked to obesity, a pr...
Recent publications highlight a frequent loss of muscle mass in chronic liver diseases, including no...
Although sarcopenia is known to be a risk factor for non-alcoholic fatty liver disease (NAFLD), whet...
Background and Aims: Frailty is very common in end-stage liver disease, regardless of disease etiolo...
Abstract Background Metabolic (dysfunction)‐associated fatty liver disease (MAFLD) emphasizes the me...
© 2022 AGA InstituteBackground & Aims: Sarcopenia and myosteatosis are associated with advanced ...
Background: Retrospective cross‐sectional studies link sarcopenia and myosteatosis with non‐alcoholi...
Nonalcoholic fatty liver disease (NAFLD) can be seen as a manifestation of overnutrition. The muscle...
Background & Aims: Adverse muscle composition (MC) (i.e., low muscle volume and high muscle fat)...
Background & Aim: Cross-sectional studies have shown lower muscle mass and strength as risk fa...
Background Adverse muscle composition (MC) as measured by magnetic resonance imaging has previously ...
Nonalcoholic fatty liver disease (NAFLD) is the most prevalent liver disease worldwide. Obesity is a...
<p><strong>Objectives</strong>: Sarcopenia is a known risk factor for non-alcoholi...
Studies exploring the relationship between muscle fat content and non-alcoholic fatty liver disease ...
Low skeletal muscle mass (LSMM) has emerged as a potential risk factor for non-alcoholic fatty liver...
BACKGROUND AND AIMS Although non-alcoholic fatty liver disease (NAFLD) is linked to obesity, a pr...
Recent publications highlight a frequent loss of muscle mass in chronic liver diseases, including no...
Although sarcopenia is known to be a risk factor for non-alcoholic fatty liver disease (NAFLD), whet...
Background and Aims: Frailty is very common in end-stage liver disease, regardless of disease etiolo...
Abstract Background Metabolic (dysfunction)‐associated fatty liver disease (MAFLD) emphasizes the me...
© 2022 AGA InstituteBackground & Aims: Sarcopenia and myosteatosis are associated with advanced ...
Background: Retrospective cross‐sectional studies link sarcopenia and myosteatosis with non‐alcoholi...
Nonalcoholic fatty liver disease (NAFLD) can be seen as a manifestation of overnutrition. The muscle...